UHC Sainte-Justine

Montreal, Quebec QC H3S 2G4

2 studies enrolling now · 4 studies all time

What they study most

Ewing Sarcoma, Liposarcoma, Neuroblastoma, Osteosarcoma, Rhabdomyosarcoma

Studies at this site

• Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors — Recruiting now
• Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma — Recruiting now
• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma — Running, not enrolling
• Neuroblastoma Maintenance Therapy Trial — Running, not enrolling